Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group (Q46691182)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group |
scientific article |
Statements
1 reference
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group (English)
1 reference
1 reference
G Fountzilas
1 reference
D Skarlos
1 reference
U Dafni
1 reference
H Gogas
1 reference
E Briasoulis
1 reference
D Pectasides
1 reference
C Papadimitriou
1 reference
A Polychronis
1 reference
H P Kalofonos
1 reference
V Siafaka
1 reference
P Kosmidis
1 reference
E Timotheadou
1 reference
D Tsavdaridis
1 reference
D Bafaloukos
1 reference
P Papakostas
1 reference
E Razis
1 reference
P Makrantonakis
1 reference
G Aravantinos
1 reference
C Christodoulou
1 reference
7 September 2005
1 reference
1 reference
16
1 reference
11
1 reference
1762-1771
1 reference
Identifiers
1 reference
1 reference